The Rehabilitation Enhancing Aging Through Connected Health Prehabilitation Trial.
Aged
Aged, 80 and over
Aging
/ physiology
Chronic Disease
Computers, Handheld
Emergency Service, Hospital
/ statistics & numerical data
Exercise Therapy
/ methods
Female
Humans
Independent Living
Longitudinal Studies
Male
Mobile Applications
Patient Compliance
/ statistics & numerical data
Physical Functional Performance
Propensity Score
Walking Speed
Aged
Healthcare
Mobility limitation
Rehabilitation
Telehealth
Journal
Archives of physical medicine and rehabilitation
ISSN: 1532-821X
Titre abrégé: Arch Phys Med Rehabil
Pays: United States
ID NLM: 2985158R
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
01
03
2019
revised:
11
04
2019
accepted:
26
04
2019
pubmed:
4
6
2019
medline:
19
3
2020
entrez:
2
6
2019
Statut:
ppublish
Résumé
To evaluate the proof of concept of an innovative model of physical therapy Rehabilitation Enhancing Aging through Connected Health (REACH) and evaluated its feasibility and effect on physical function and health care utilization. Quasi-experimental 12-month clinical trial. Two outpatient rehabilitation centers. Community-dwelling older primary care patients with a treatment arm undergoing the intervention (n=75; mean age=77±5.9y; 54% women) and propensity matched controls derived from a longitudinal cohort study (n=430; mean age=71±7.0y; 68% women) using identical recruitment criteria (N=505). Combined outpatient and home PT augmented with a commercially available app and computer tablet. Primary outcomes included a feasibility questionnaire, exercise adherence, self-reported function, and the Short Physical Performance Battery (SPPB). Secondary outcomes included the rates of emergency department (ED) visits and hospitalizations. Among REACH participants, we observed a 9% dropout rate. After accounting for dropouts, with propensity matching, n=68 treatments and n=100 controls were analyzed. Over the 12-month study duration, 85% of participants adhered to the exercise program an average of 2 times a week and evaluated the treatment experience favorably. In comparison to controls, after 1 year of treatment and within multivariable regression models, REACH participants did not manifest a significant difference in patient reported function (group x time effect 1.67 units, P=.10) but did manifest significant differences in SPPB (group x time effect 0.69 units, P=.03) and gait speed (group x time effect .08m/s, P=.02). In comparison to controls, after 1 year, the rate of ED visits (group x time treatment rate=0.27, P<.004) were significantly reduced, but a significant reduction in hospitalizations was not observed. The REACH intervention is feasible and has proof of concept in preventing functional decline and favorably affecting health care utilization. Evaluation on a larger scale is warranted.
Identifiants
pubmed: 31152705
pii: S0003-9993(19)30380-6
doi: 10.1016/j.apmr.2019.04.015
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT02580409']
Types de publication
Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1999-2005Subventions
Organisme : NIA NIH HHS
ID : R01 AG032052
Pays : United States
Informations de copyright
Published by Elsevier Inc.